Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 985 | 877 | 985 | 1028 | 1325 | 2025 |
Fund Return | -1.53% | -12.29% | -1.53% | 0.93% | 5.79% | 7.31% |
Place in category | 145 | 160 | 145 | 46 | 68 | 52 |
% in Category | 77 | 85 | 77 | 23 | 40 | 45 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Stock Market Ins Pls | 714.4B | 23.76 | 7.88 | - | ||
Vanguard 500 Index Admiral | 562.19B | 24.97 | 8.89 | 13.06 | ||
Vanguard Total Stock Market Admiral | 406.82B | 23.74 | 7.86 | 12.49 | ||
Vanguard Total Intl Stock Index Inv | 201.2B | 5.09 | 0.61 | 5.00 | ||
Vanguard 500 Index Institutional Se | 200.46B | 25.00 | 8.93 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Select Health Care | 10.35B | 4.93 | -1.61 | 8.22 | ||
T. Rowe Price Health Sciences | 8B | 1.82 | -2.69 | 8.69 | ||
Fidelity Advisor Health Care I | 6.23B | 4.17 | -1.87 | 7.68 | ||
Fidelity Advisor Health Care T | 6.23B | 3.66 | -2.37 | 7.13 | ||
Fidelity Advisor Health Care A | 6.23B | 3.90 | -2.12 | 7.40 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.57 | 820.31 | +2.02% | |
UnitedHealth | US91324P1021 | 7.62 | 544.77 | +1.24% | |
AstraZeneca | GB0009895292 | 5.64 | 11,314.0 | +0.73% | |
Merck&Co | US58933Y1055 | 4.49 | 99.04 | +0.77% | |
Novo Nordisk B | DK0062498333 | 3.90 | 603.7 | -0.66% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Sell | Strong Sell |
Technical Indicators | BUY | Strong Sell | Strong Sell |
Summary | Neutral | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review